Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
Fierce Biotech M&A Tracker 2023: GreenLight, Apexigen and more
Fierce Biotech's M&A Tracker, your one-stop shop for dealmaking in the biopharma universe.
Annalee Armstrong
,
Max Bayer
,
Gabrielle Masson
Jun 1, 2023 9:24am
Rain lays off 65% of workforce after phase 3 fail
May 30, 2023 11:08am
Fierce Biotech Fundraising Tracker: Carmot; ElevateBio & more
May 26, 2023 4:30am
ElevateBio hits 2023 high with $401M series D
May 24, 2023 6:00am
New RNA biotech raises $300M in largest private round of 2023
May 23, 2023 6:30am
Fierce Biotech's Fierce 15 nominations are NOW OPEN
May 22, 2023 6:00am
More News
Siren wants gene therapy, cancer to 'get into the weeds'
May 18, 2023 11:00am
SPAC in business: Gene therapy biotech takes blank-check route
May 17, 2023 11:17am
Takeda puts $510M on the line to expand KSQ cancer collaboration
May 17, 2023 9:35am
Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal
May 16, 2023 9:00am
See more stories